- Home
- CEV vs TNYA Comparison
CEV vs TNYA Comparison
Compare CEV & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- TNYA
- Stock Information
- Founded
- CEV 1999
- TNYA 2016
- Country
- CEV United States
- TNYA United States
- Employees
- CEV N/A
- TNYA N/A
- Industry
- CEV Finance/Investors Services
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- CEV Finance
- TNYA Health Care
- Exchange
- CEV Nasdaq
- TNYA Nasdaq
- Market Cap
- CEV 67.8M
- TNYA 74.5M
- IPO Year
- CEV N/A
- TNYA 2021
- Fundamental
- Price
- CEV $9.62
- TNYA $0.46
- Analyst Decision
- CEV
- TNYA Strong Buy
- Analyst Count
- CEV 0
- TNYA 6
- Target Price
- CEV N/A
- TNYA $8.60
- AVG Volume (30 Days)
- CEV 19.6K
- TNYA 2.3M
- Earning Date
- CEV 01-01-0001
- TNYA 05-07-2025
- Dividend Yield
- CEV 4.23%
- TNYA N/A
- EPS Growth
- CEV N/A
- TNYA N/A
- EPS
- CEV 0.36
- TNYA N/A
- Revenue
- CEV N/A
- TNYA N/A
- Revenue This Year
- CEV N/A
- TNYA N/A
- Revenue Next Year
- CEV N/A
- TNYA N/A
- P/E Ratio
- CEV $29.36
- TNYA N/A
- Revenue Growth
- CEV N/A
- TNYA N/A
- 52 Week Low
- CEV $8.83
- TNYA $0.36
- 52 Week High
- CEV $10.91
- TNYA $4.29
- Technical
- Relative Strength Index (RSI)
- CEV 42.26
- TNYA 48.93
- Support Level
- CEV $9.56
- TNYA $0.43
- Resistance Level
- CEV $9.82
- TNYA $0.46
- Average True Range (ATR)
- CEV 0.08
- TNYA 0.04
- MACD
- CEV -0.01
- TNYA 0.01
- Stochastic Oscillator
- CEV 32.35
- TNYA 71.43
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.